AR
Advisory Research’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.23M | Buy |
240,421
+13,172
| +6% | +$506K | 1.42% | 23 |
|
|
2025
Q1 | $8.8M | Sell |
227,249
-14,725
| -6% | -$570K | 1.55% | 23 |
|
|
2024
Q4 | $8.18M | Sell |
241,974
-20,103
| -8% | -$680K | 1.36% | 25 |
|
|
2024
Q3 | $10.7M | Sell |
262,077
-5,842
| -2% | -$239K | 1.9% | 19 |
|
|
2024
Q2 | $10.3M | Buy |
267,919
+143,346
| +115% | +$5.52M | 1.94% | 16 |
|
|
2024
Q1 | $5.34M | Sell |
124,573
-7,367
| -6% | -$316K | 1.06% | 31 |
|
|
2023
Q4 | $4.89M | Buy |
131,940
+6,099
| +5% | +$226K | 0.75% | 33 |
|
|
2023
Q3 | $4.56M | Buy |
125,841
+115,026
| +1,064% | +$4.17M | 0.63% | 34 |
|
|
2023
Q2 | $385K | Buy |
10,815
+2,418
| +29% | +$86.2K | 0.05% | 338 |
|
|
2023
Q1 | $299K | Buy |
+8,397
| New | +$299K | 0.05% | 292 |
|
|
2015
Q1 | – | Sell |
-14,165
| Closed | -$605K | – | 342 |
|
|
2014
Q4 | $605K | Sell |
14,165
-2,260
| -14% | -$96.5K | 0.01% | 293 |
|
|
2014
Q3 | $755K | Buy |
16,425
+1,545
| +10% | +$71K | 0.01% | 277 |
|
|
2014
Q2 | $796K | Sell |
14,880
-1,860
| -11% | -$99.5K | 0.01% | 270 |
|
|
2014
Q1 | $894K | Buy |
16,740
+700
| +4% | +$37.4K | 0.01% | 256 |
|
|
2013
Q4 | $856K | Sell |
16,040
-6,730
| -30% | -$359K | 0.01% | 253 |
|
|
2013
Q3 | $1.14M | Sell |
22,770
-5,990
| -21% | -$301K | 0.01% | 233 |
|
|
2013
Q2 | $1.44M | Buy |
+28,760
| New | +$1.44M | 0.02% | 217 |
|